ScoreWhy is Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -3.78% and Operating profit at -6.52% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 4.72% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -3.78% and Operating profit at -6.52% over the last 5 years
3
With ROE of 4.48%, it has a very expensive valuation with a 1.76 Price to Book Value
- Over the past year, while the stock has generated a return of -10.31%, its profits have fallen by -0.2%
4
Below par performance in long term as well as near term
- Along with generating -10.31% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.
-100.0%
0.12
32.59%
China Shanghai Composite
16.78%
1.40
13.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.78%
EBIT Growth (5y)
-6.52%
EBIT to Interest (avg)
34.61
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.26
Tax Ratio
13.74%
Dividend Payout Ratio
50.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.15%
ROE (avg)
4.72%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
1.76
EV to EBIT
37.20
EV to EBITDA
26.19
EV to Capital Employed
1.96
EV to Sales
5.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.27%
ROE (Latest)
4.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -7.74% (YoY
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.
Raw Material Cost
Fallen by -7.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
